ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

16 Tips from 16 Years Sick

Fibromyalgia Fare Fit for All Seasons

New Study Shows Artificial Sweeteners Lead to Diabetes

Essential Oils — An Effective and Healthy Option to Treat Headaches

Higher vitamin D levels associated with less severe disease in NAFLD patients

Krill Oil: Make This Omega-3 Supplement Part of Your Health Regimen

How zinc helps fight esophageal cancer

Everything You Need to Know About Black Cohosh

Low vitamin D levels predict ED in diabetics

Let Sweet Basil Oil Boost Your Health Today

 
Print Page
Email Article

Estimates of the Prevalence and Number of Fibromyalgia Syndrome Patients and Their Alpha-1 Antitrypsin Phenotypic Distribution in Ten Countries - Source: Journal of Musculoskeletal Pain, Vol 15, #4 2007

  [ 373 votes ]   [ Discuss This Article ]
By Ignacio Blanco, MD, et al. • www.ProHealth.com • October 4, 2007


[Note: Alpha-1 Antitrypsin is a protein made by the liver and released into the bloodstream. AAT deficiency is an inherited disorder that may be moderate or severe depending on the combination of genetic alleles. A blood test can detect it, and it can be treated but not cured. Depending on their allele patterns, some individuals with this disorder develop impaired lung or liver function.]

Objectives: During the last few years, clinical, epidemiological, and pathological evidence has suggested that inherited alpha-1 antitrypsin [AAT] deficiency might play a role in the development of the Fibromyalgia syndrome [FMS], probably because of the loss of AAT anti-inflammatory efficacy. The objective of this study was to estimate the prevalence and number of FMS patients, and their AAT phenotypic distribution worldwide.

Methods: A critical review selecting reliable studies on the subject.

Results: Studies on AAT gene frequencies and FMS prevalence were retrieved for ten countries worldwide, namely Canada, the United States of America [USA], Denmark, Finland, Germany, Italy, the Netherlands, Spain, Sweden, and Pakistan.

The severe deficiency Z allele was found in all these countries, with:

  • Very high frequencies in Denmark and Sweden [23 and 27 per 1,000, respectively],

  • High frequencies in Italy and Spain [16 and 17 per 1,000],
  • Intermediate frequencies in Germany, the Netherlands, Canada, and the USA [10 to 14 per 1,000],

  • And a low frequency in Pakistan [9 per 1,000].
  • The calculated prevalence of AAT deficiency and the number of FMS patients with AAT deficiency were:

  • 1/10 and 25,408 in Canada,

  • 1/11 and 478,681 in the US,

  • 1/9 and 3,124 in Denmark,

  • 1/ 36 and 726 in Finland,

  • 1/16 and 48,523 in Germany,

  • 1/13 and 84,876 in Italy,

  • 1/15 and 9,639 in the Netherlands,

  • 1/4 and 114,359 in Spain,

  • 1/11 and 9,065 in Sweden,

  • And 1/25 and 85,965 in Pakistan.
  • Our calculations predict that AAT deficiency would remain undetected in around nine percent of FMS patients, with about eight percent of them carrying moderate deficiency phenotypes [MS, SS, and MZ], and less than one percent with severe deficiency phenotypes [SZ and ZZ].

    Conclusions: Therefore, AAT phenotype characterization should be recommended in FMS patients and the possible efficacy of AAT replacement therapy in severe deficiency FMS patients should warrant further studies.

    Source: Journal of Musculoskeletal Pain, 2007. Vol 15, Issue 4, pp. 9-23. DOI: 10.1300/J094v15n04_03, by Blanco I, de Serres F, Janciauskiene S, Arbesú D, Fernández-Bustillo E, Cárcaba V, Nita I, Astudillo A. Department of Internal Medicine, Hospital Valle del Nalón, Langreo, Spain [E-mail: Ignacio.blanco@sespa.princast.es]





    Post a Comment

    Featured Products From the ProHealth Store
    FibroSleep™ Mitochondria Ignite™ with NT Factor® Ultra EPA  - Fish Oil


    Article Comments



    Be the first to comment on this article!

    Post a Comment


     
    Optimized Curcumin Longvida with Omega-3

    Featured Products

    Ultra ATP+, Double Strength Ultra ATP+, Double Strength
    Get energized with malic acid & magnesium
    FibroSleep™ FibroSleep™
    The All-in-One Natural Sleep Aid
    Energy NADH™ 12.5mg Energy NADH™ 12.5mg
    Improve Energy & Cognitive Function
    Optimized Curcumin Longvida® Optimized Curcumin Longvida®
    Supports Cognition, Memory & Overall Health
    Vitamin D3 Extreme™ Vitamin D3 Extreme™
    50,000 IU Vitamin D3 - Prescription Strength

    Natural Remedies

    Coenzyme Q10 - The Energy Maker Coenzyme Q10 - The Energy Maker
    Secret Nutrient for Radiant Skin Secret Nutrient for Radiant Skin
    Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial
    The Remarkable Benefits of Reishi Medicinal Mushrooms The Remarkable Benefits of Reishi Medicinal Mushrooms
    More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History

    CONTACT US
    ProHealth, Inc.
    555 Maple Ave
    Carpinteria, CA 93013
    (800) 366-6056  |  Email

    · Become a Wholesaler
    · Vendor Inquiries
    · Affiliate Program
    SHOP WITH CONFIDENCE
    Credit Card Processing
    SUBSCRIBE TO OUR NEWSLETTERS
    Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

    CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

    © 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map